{"id":21256,"date":"2024-08-28T15:55:53","date_gmt":"2024-08-28T15:55:53","guid":{"rendered":"https:\/\/allonlinebanglanewspapers.com\/news\/innovative-new-copd-maintenance-treatment-now-available-through-directrx-specialty-pharmacy\/"},"modified":"2024-08-28T15:55:53","modified_gmt":"2024-08-28T15:55:53","slug":"innovative-new-copd-maintenance-treatment-now-available-through-directrx-specialty-pharmacy","status":"publish","type":"post","link":"https:\/\/allonlinebanglanewspapers.com\/news\/innovative-new-copd-maintenance-treatment-now-available-through-directrx-specialty-pharmacy\/","title":{"rendered":"Innovative New COPD Maintenance Treatment Now Available Through DirectRx Specialty Pharmacy"},"content":{"rendered":"
\n

Ohtuvayre\u2122 (ensifentrine) is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in adult patients in more than 13 years<\/p>\n

TROY, Mich., Aug. 28, 2024 (GLOBE NEWSWIRE) — DirectRx,<\/a> a leading national specialty pharmacy dedicated to serving individual patients with complex and chronic health needs, today announced that is has been selected to be part of the exclusive distribution network for the newest and first-in-class COPD medication, Ohtuvayre by Verona Pharma. The announcement was made by Alban Ivezaj, President of DirectRx.<\/p>\n

\u201cWe followed the clinical trials closely which found that Ohtuvayre demonstrated both early and sustained improvements in lung function across a broad population of patients with COPD,\u201d said Amanda Berishaj, DirectRx VP of Clinical Services. \u201cWith our expertise in COPD, we are excited to be partnering with Verona Pharma on the launch on their novel and innovative therapy.\u201d<\/p>\n

Ohtuvayre was approved by the FDA on June 26 and is now available for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. The new treatment is simple and effective, combining a bronchodilator and non-steroidal anti-inflammatory effects in one molecule. The treatment is delivered directly to the lungs through a standard jet nebulizer without the need for any complex hand-breath coordination.<\/p>\n

As a broad label therapy, Ohtuvayre can be prescribed as a monotherapy or as an add-on medication with current therapies for COPD. Ohtuvayre is Verona Pharma\u2019s brand name for ensifentrine, a selective dual inhibitor of PDE3\/4.<\/p>\n

\u201cWe are honored to be selected as part of Ohtuvayre\u2019s exclusive distribution network of accredited pharmacy partners,\u201d said Ivezaj. \u201cThousands of prescribers across the United States trust DirectRx with their patients\u2019 COPD medications \u2013 we are excited to be able to support these prescriber partners with Ohtuvayre.\u201d<\/p>\n

DirectRx<\/em><\/strong><\/a>,<\/em> an independent specialty pharmacy with dual accreditation from both ACHC and URAC, provides patients with unparalleled, personalized pharmaceutical care. <\/em>The company continues to invest in technology and people to provide unparalleled service to patients and doctors in all 50 states<\/em>. <\/em>www.DirectRx.com<\/a><\/em><\/p>\n

CONTACT:<\/strong>\u00a0Marina Lekocaj, DirectRx (248) 273-0489<\/p>\n

\n <\/div>\n","protected":false},"excerpt":{"rendered":"

Ohtuvayre\u2122 (ensifentrine) is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in adult patients in more than 13 years TROY, Mich., Aug. 28, 2024 (GLOBE NEWSWIRE) — DirectRx, a leading national specialty pharmacy dedicated to serving individual patients with complex and chronic health needs, today announced […]<\/p>\n","protected":false},"author":2,"featured_media":21257,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/0aa3e283-a8ab-4a28-9548-d8225e312040","fifu_image_alt":"","footnotes":""},"categories":[11],"tags":[],"class_list":["post-21256","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t